Meeting
2020 ASCO Virtual Scientific Program
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
Authors
Lynda M McSorley
Galway University Hospital, Galway, Ireland
Lynda M McSorley , Fathiya Al Rahbi , Mehala Tharmabala , Denis Evoy , James G. Geraghty , Ruth Prichard , Jane Rothwell , Damian McCartan , Enda McDermott , Maccon M. Keane , John Kennedy , Seamus O'Reilly , Steve Millen , John Crown , Lillian Mary Smyth , Catherine Margaret Kelly , Cecily Quinn , Janice Maria Walshe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 38: 2020 (suppl; abstr 540)
DOI
10.1200/JCO.2020.38.15_suppl.540
Abstract #
540
Poster Bd #
32
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial.
First Author: Nagi S. El Saghir
Poster
2023 ASCO Annual Meeting
An analysis of breast cancer index scores predicting benefit of extended endocrine therapy by race.
First Author: Nicholas Siu-Li
Poster
2021 ASCO Annual Meeting
Validation of the RSClin risk calculator using the National Cancer Database (NCDB).
First Author: Frederick Howard
Poster
2019 ASCO Quality Care Symposium
“I had already made up my mind.” The impact of prior experience and health care perceptions on decision making in women with early-stage breast cancer.
First Author: Rebecca England